S&T Bank’s HCA Healthcare HCA Stock Holding History

S&T Bank’s Portfolio HCA Stock Details HCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-42	Closed	-$17.9K	–	454
2025 Q3	$17.9K	Buy	+42	New	+$16.3K	0.01%	214

Other funds holding HCA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

S&T Bank's HCA Position: Q4 2025 in Review

S&T Bank sold out of HCA Healthcare (HCA) in Q4 2025, closing a stake of 42 shares — an estimated $17.9K sold.

S&T Bank first reported a position in HCA in Q3 2025 and held it in 1 quarter. The position peaked at $17.9K in Q3 2025. 1,399 funds tracked by Wall St. Rank hold HCA as of Q4 2025.

S&T Bank reported no remaining HCA Healthcare position as of Q4 2025 after selling out during the quarter.
S&T Bank sold 42 HCA Healthcare shares in Q4 2025, an estimated $17.9K.
S&T Bank first reported a position in HCA Healthcare in Q3 2025 and held it in 1 quarter.
S&T Bank's HCA Healthcare position peaked at $17.9K in Q3 2025.
1,399 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2025.

Based on S&T Bank's 13F filing for Q4 2025, filed 13 Feb 2026.